Clinical Trials · NCT07803744
A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
- Phase
- Phase 1
- Recruitment status
- Recruiting
- Sponsor
- Eli Lilly and Company
- Enrollment
- 18
- Start date
- Sep 2026
- Locations
- 1 site, United States
- Primary endpoint
- Pharmacokinetics (PK): Time of Maximum Observed Drug Concentration (Tmax) of Acetaminophen